Intensity-modulated radiotherapy plan optimisation for skull base lesions: Practical class solutions for dose escalation

Clinical Oncology

Volumn 22, Issue 4, 2010, Pages 313-320

  Estall, V J ^a   Eaton, D ^b   Burton, K E ^c   Jefferies, S J ^c   Jena, R ^c   Burnet, N G ^b,d  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Class solutions; IMRT; Meningioma; Skull base

Indexed keywords

ARTICLE; CLINICAL ARTICLE; COLLIMATOR; COMPUTER PROGRAM; CONTROLLED STUDY; DOSIMETRY; EVIDENCE BASED MEDICINE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LINEAR ACCELERATOR; MENINGIOMA; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RADIATION BEAM; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION SAFETY; SKULL BASE TUMOR; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR LOCALIZATION; TUMOR VOLUME;

HUMANS; MENINGEAL NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; SKULL BASE NEOPLASMS; TREATMENT OUTCOME;

EID: 77951766098     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2010.02.002     Document Type: Article

References (34)

1. Baumert B.G., Norton I.A., Davis J.B. Intensity modulated stereotactic radiotherapy vs stereotactic conformal radiotherapy for the treatment of meningioma located predominantly in the skull base. Int J Radiat Oncol Biol Phys 2003, 57:580-592.
2. Burton K.E., Thomas S.J., Whitney D., et al. Accuracy of relocatable stereotactic radiotherapy head frame evaluated by use of a depth helmet. Clin Oncol 2002, 14:31-39.
3. McKenzie A., van Herk M., Mijnheer B. Margins for geometric uncertainty around organs at risk in radiotherapy. Radiother Oncol 2002, 62:299-307.
4. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991, 21:190-220.
5. Parsons J.T., Bova F.J., Fitzgerald C.R., Mendenhall W.M., Million R.R. Radiation optic neuropathy after megavoltage external beam irradiation: analysis of time dose factors. Int J Radiat Oncol Biol Phys 1994, 30:755-763.
6. Debus J., Wuendrich M., Pirzkall A., et al. High efficacy of fractionated stereotactic radiotherapy of large base of skull meningiomas - long term results. J Clin Oncol 2001, 19:3547-3553.
7. Debus J., Hug E.B., Leibsch N.J., et al. Brainstem tolerance to conformal radiotherapy of skull base tumours. Int J Radiat Oncol Biol Phys 1997, 39:967-975.
8. Parsons J.T., Bova F.J., Fitzgerald C.R., Mendenhall W.M., Million R.R. Radiation retinopathy after external-beam irradiation: analysis of time dose factors. Int J Radiat Oncol Biol Phys 1994, 30:765-773.
9. Henk J.M., Whitelocke R.A., Warrington A.P., et al. Radiation dose to the lens and cataract formation. Int J Radiat Oncol Biol Phys 1993, 25:815-820.
10. Coderre J.A., Morris G.M., Micca P.L., et al. Late effects of radiation on the central nervous system: role of vascular endothelial damage and glial stem cell survival. Radiat Res 2006, 166:495-503.
11. Lyubimova M., Hopewell J.W. Experimental evidence to support the hypothesis that damage to vascular endothelium plays the primary role in the development of late radiation-induced CNS injury. Br J Radiol 2004, 77:488-492.
12. Takeda A., Shigematsu N., Suzuki S., et al. Late retinal complications of radiation therapy for nasal and paranasal malignancies: relationship between irradiated-dose area and severity. Int J Radiat Oncol Biol Phys 1999, 44:599-605.
13. Daley M.E., Chen A.M., Bucci M.K., et al. Intensity-modulated radiation therapy for malignancies of the nasal cavities and paranasal sinus. Int J Radiat Oncol Biol Phys 2007, 67:151-157.
14. Schmiegelow M., Lassen S., Weber L., Poulsen H.S., Hertz H., Muller J. Dosimetry and growth hormone deficiency following cranial irradiation of childhood brain tumours. Med Pediatr Oncol 1999, 33:564-571.
15. Merchant T.E., Goloubeva O., Pritchard D.L., et al. Radiation dose-volume effects on growth hormone secretion. Int J Radiat Oncol Biol Phys 2002, 52:1264-1270.
16. Pai H.H., Thornton A., Katznelson L., et al. Hypothalamic/pituitary function following high dose conformal radiotherapy to the base of skull: demonstration of a dose effect relationship using dose volume histogram analysis. Int J Radiat Oncol Biol Phys 2001, 49:1079-1092.
17. Niemierko A. Reporting and analysing dose distributions: a concept of equivalent uniform dose. Med Phys 1997, 24:103-110.
18. Thomas E., Chapet O., Kessler M.L., et al. Benefit of using biological parameters (EUD and NTCP) in IMRT optimization for treatment of intrahepatic tumors. Int J Radiat Oncol Biol Phys 2005, 62:571-578.
19. Wu Q., Mohan R., Niemierko A., et al. Optimization of intensity-modulated radiotherapy plans based on equivalent uniform dose. Int J Radiat Oncol Biol Phys 2002, 52:224-235.
20. Followill D., Geis P., Boyer A. Estimates of whole-body dose equivalent produced by beam intensity modulated conformal therapy. Int J Radiat Oncol Biol Phys 1997, 38:667-672.
21. Schneider U., Lomax A., Pemler P., et al. The impact of IMRT and proton radiotherapy on secondary cancer incidence. Strahlenther Onkol 2006, 182:647-652.
22. Pirzkall A., Carol M., Lohr F., et al. Comparison of intensity-modulated radiotherapy with conventional conformal radiotherapy for complex shaped tumors. Int J Radiat Oncol Biol Phys 2000, 48:1371-1380.
23. Foweraker K.L., Burton K.E., Maynard S.E., et al. High-dose radiotherapy in the management of chordoma and chondrosarcoma of the skull base and cervical spine: part 1. Clinical outcomes. Clin Oncol 2007, 19:509-516.
24. Schulz-Ertner D., Karger C.P., Feuerhake A., et al. Effectiveness of carbon ion radiotherapy in the treatment of skull base chordomas. Int J Radiat Oncol Biol Phys 2007, 68:449-457.
25. Fu K.K., Pajak T.F., Trotti A., et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000, 48:7-16.
26. Goldsmith B., Wara W., Wilson C., et al. Postoperative radiation for sub totally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 1994, 80:195-201.
27. Milosevic M.F., Frost P.J., Laperriere N.J., et al. Radiotherapy for atypical or malignant intracranial meningioma. Int J Radiat Oncol Biol Phys 1996, 34:817-822.
28. Hug E., Devries A., Thornton A., et al. Management of atypical and malignant meningiomas: role of high dose, 3D conformation radiation therapy. J Neurooncol 2000, 48:151-160.
29. Wiggenraad RG, Petoukhova AL, Versluis L, et al. Stereotactic radiotherapy of intracranial tumours: a comparison of intensity-modulated radiotherapy and dynamic conformal arc therapy. Int J Radiat Oncol Biol Phys (in press).
30. Nill S., Tucking T., Munter M.W., Oelfke U. Intensity modulated radiation therapy with multileaf collimators of different leaf widths: a comparison of achievable dose distributions. Radiother Oncol 2005, 75:106-111.
31. Fiveash J.B., Murshed H., Duan J., et al. Effect of multileaf collimator on physical dose distributions in the treatment of CNS and head and neck neoplasms with intensity modulated radiotherapy. Med Phys 2002, 29:1116-1119.
32. Monk J.E., Perks J.R., Doughty D., Plowman P.N. Comparison of a micro-multileaf collimator with a 5mm leaf width collimator for intracranial stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 2003, 57:1443-1449.
33. Das S., Cullip T., Tracton G., et al. Beam orientation selection for intensity modulated radiation therapy based on target equivalent uniform dose maximisation. Int J Radiat Oncol Biol Phys 2003, 55:215-224.
34. Kellar-Reichenbecher M., Bortfeld T., Levegrun S., et al. Intensity modulation with the 'step and shoot' technique using a commercial MLC: a planning study. Int J Radiat Oncol Biol Phys 2004, 45:1315-1324.